Market Tracker

07/30 3:14pm ET
4.57
Real-Time Quote
 +0.07 / +1.56%
Today’s Change
2.24
Today|||52-Week Range
6.95
-10.74%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close4.50
Today’s open4.59
Day’s range4.48 - 4.63
Volume2,478,520
Average volume (3 months)3,924,985
Market cap$1.1B
Dividend yield--
Data as of 2:59pm ET, 07/30/2014

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)+16.77%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book4.62

Competitors

 Today’s
change
Today’s
% change
HALOHalozyme Therapeutic...-0.44-4.63%
BLUEbluebird bio Inc+0.43+1.27%
IMGNImmunoGen Inc+0.14+1.28%
AEGRAegerion Pharmaceuti...+4.94+16.13%
Data as of 3:13pm ET, 07/30/2014

Financials

Next reporting dateAugust 8, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
SVP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts